Vergleich

Dexamethasone Europäischer Partner

ArtNr HY-14648-500mg
Hersteller MedChem Express
CAS-Nr. 50-02-2
Menge 500 mg
Quantity options 100 mg 10 mM/1 mL 1 g 500 mg 5 g
Kategorie
Typ Inhibitors
Specific against other
Purity 99.86
Citations [1]LaLone CA, et al. Effects of a glucocorticoid receptor agonist, Dexamethasone, on fathead minnow reproduction, growth, and development. Environ Toxicol Chem. 2012 Mar;31(3):611-22.|[2]Adcock IM, et al. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol. 1999 Jun;127(4):1003-11|[3]Ballabh P, et al. Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids. Arch Dis Child Fetal Neonatal Ed. 2004 Jan;89(1):F76-83.|[4]Yun Chen, et al. Glucocorticoids inhibit production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses. Int J Clin Exp Pathol 2018;11(7):3391-3397.|[5]Yoshioka Y, et al. Glabridin inhibits dexamethasone-induced muscle atrophy. Arch Biochem Biophys. 2019 Mar 30;664:157-166.|[6]Troncoso R, et al. Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance. Cell Cycle. 2014;13(14):2281-95.|[7]Ong SL, et al. Hemodynamics of dexamethasone-induced hypertension in the rat. Hypertens Res. 2009 Oct;32(10):889-94.|[8]Nakamoto H, et al. Characterization of alterations of hemodynamics and neuroendocrine hormones in dexamethasone induced hypertension in dogs. Clin Exp Hypertens A. 1991;13(4):587-606.|[9]Mesripour A, et al. The effect of vitamin B6 on dexamethasone-induced depression in mice model of despair. Nutr Neurosci. 2019 Oct;22(10):744-749. |[10]Bhatt S, et al. Role of Aspirin and Dexamethasone against Experimentally Induced Depression in Rats. Basic Clin Pharmacol Toxicol. 2016 Jul;119(1):10-8.|[11]Song D, et al. Physiologically Based Pharmacokinetics of Dexamethasone in Rats. Drug Metab Dispos. 2020 Sep;48(9):811-818.
ACS Biomater Sci Eng. 2022 Nov 14;8(11):4850-4862.
ACS Chem Neurosci. 2023 Jun 21;14(12):2362-2374.
ACS Infect Dis. 2025 Oct 10;11(10):2814-2820.
ACS Nano. 2023 Dec 26;17(24):25377-25390.
ACS Nano. 2024 Aug 13;18(32):21009-21023.
ACS Nano. 2025 Mar 4;19(8):7728-7741.
Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):908-914.
Acta Biomater. 2022 Dec:154:194-211.
Acta Pharm Sin B. 2024 Apr 23.
Acta Pharm Sin B. 2025 Aug 5.
Acta Pharm Sin B. 2025 Nov 13.
Acta Pharmacol Sin. 2020 Jan;41(1):10-21.
Acta Pharmacol Sin. 2021 Jan;42(1):108-114.
Acta Pharmacol Sin. 2022 Sep;43(9):2429-2438.
Acta Pharmacol Sin. 2025 Aug;46(8):2296-2309.
Adipocyte. 2022 Dec;11(1):202-212.
Adipocyte. 2022 Dec;11(1):562-571.
Adv Funct Mater. 2025 Apr 21.
Adv Funct Mater. 2025 May 22.
Adv Healthc Mater. 2025 Aug 11:e00602.
Adv Healthc Mater. 2025 Jun 25:e2500867.
Adv Mater. 2024 Dec 26:e2415543.
Adv Sci (Weinh). 2022 Jan;9(3):e2102435.
Adv Sci (Weinh). 2022 Sep;9(26):e2202505.
Adv Sci (Weinh). 2024 Nov 2:e2406766.
Adv Sci (Weinh). 2025 Apr 15:e2415846.
Adv Sci (Weinh). 2025 May 30:e14902.
Adv Sci (Weinh). 2025 Nov 14:e14514.
Adv Sci (Weinh). 2025 Nov 21:e08472.
Adv Sci (Weinh). 2025 Oct 28:e16569.
Allergy. 2025 Jul 25.
Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E696-E708.
Antioxidants (Basel). 2021 Aug 24;10(9):1333.
Arch Med Res. 2018 Jul;49(5):335-341.
Atherosclerosis. 2026 Jan:412:120594.
Authorea. 2023 Jan 27.
BIO Web of Conferences. 2025 May 12.
Bioact Mater. 2024 May 6:37:549-562.
Biochem Biophys Res Commun. 2019 Jun 11;513(4):1019-1026.
Biochem Biophys Res Commun. 2023 May 21:657:108-118.
Biochem Biophys Res Commun. 2024 Nov 26:735:150865.
Biochem Pharmacol. 2020 Oct;180:114145.
Biochem Pharmacol. 2025 Jun:236:116870.
Biochim Biophys Acta Mol Basis Dis. 2025 May 13:167904.
Biochim Biophys Acta Mol Cell Res. 2025 Jan 27:119911.
Biomaterials. 2020 Feb;232:119730.
Biomaterials. 2025 Jun 17:324:123513.
Biomed Pharmacother. 2021 Jul:139:111590.
Biomed Pharmacother. 2024 Apr:173:116346.
Biomed Res Int. 2022 Jul 23:2022:8080679.
Biomedicines. 2025 Mar 3;13(3):614.
Biomolecules. 2025 Nov 19;15(11):1623.
Bioorg Chem. 2022 Dec:129:106206.
bioRxiv. 2023.
bioRxiv. 2024 August 11.
bioRxiv. 2024 Jul 7:2024.07.04.601620.
bioRxiv. 2025 February 22.
bioRxiv. 2025 January 19.
bioRxiv. 2025 March 25.
Biotechnol J. 2025 Jul;20(7):e70080.
BMC Med. 2025 May 30;23(1):316.
Bone Res. 2025 Jan 26;13(1):18.
Bone Res. 2025 Mar 3;13(1):30.
Bone. 2024 Aug 3:117222.
Br J Pharmacol. 2021 Aug;178(15):2976-2997.
Brain Behav Immun. 2025 Sep 21:130:106118.
Cancer Res. 2025 Sep 10.
Carbohydr Polym. 2023 Jan 1:299:120179.
Cell Biochem Biophys. 2025 Jun;83(2):2115-2126.
Cell Biol Toxicol. 2025 Mar 7;41(1):56.
Cell Commun Signal. 2025 Feb 5;23(1):65.
Cell Mol Life Sci. 2025 Nov 19;82(1):412.
Cell Prolif. 2024 Jul 24:e13720.
Cell Rep Med. 2025 Apr 25:102098.
Cell Rep Med. 2025 Jul 15;6(7):102215.
Cell Rep. 2024 Feb 17;43(2):113804.
Cell Tissue Res. 2024 Jan;395(1):63-79.
Cell Transplant. 2023 Jan-Dec:32:9636897231177356.
Cell Transplant. 2025 Jan-Dec:34:9636897251376125.
Cell. 2023 Jun 22;186(13):2823-2838.e20.
Ceram Int. 2025 Nov 7.
Chem Eng J. 2023 Aug 6, 145212.
Chem Eng J. 2025 Oct 8;524:169421.
Chem Mater. 2017, 29(19):8221-8238.
Chin Herb Med. 2024 Apr 30.
Clin Exp Pharmacol Physiol. 2024 Nov;51(11):e13923.
Clin Transl Med. 2023 Jul;13(7):e1326.
Collagen Leather. 2025 Nov 19,7(1):39.
Commun Biol. 2022 Nov 26;5(1):1295.
Commun Biol. 2024 Nov 28;7(1):1589.
Commun Biol. 2025 Aug 27;8(1):1291.
Commun Biol. 2025 Jul 29;8(1):1127.
Commun Biol. 2025 Jul 30;8(1):1134.
Comput Biol Med. 2023 Mar:154:106607.
Curr Biol. 2024 May 21:S0960-9822(24)00603-1.
Curr Eye Res. 2022 Aug;47(8):1156-1164.
Cytotechnology. 2026 Feb;78(1):5.
Dermatol Clin. 2025 August 20.
Drug Des Devel Ther. 2022 Nov 15:16:3929-3946.
Drug Test Anal. 2021 Feb;13(2):283-298.
Ecotoxicol Environ Saf. 2021 Aug 16:224:112632.
Ecotoxicol Environ Saf. 2022 Dec 15:248:114315.
Endocr J. 2022 Apr 28;69(4):385-397.
Endocrine. 2025 May 24.
Endocrinology. 2022 Dec 19;164(2):bqac203.
Eur J Med Chem. 2021 Dec 5:225:113743.
Eur J Med Chem. 2022 Jul 5:237:114382.
Eur J Med Chem. 2023 Oct 5:258:115602.
Eur J Med Chem. 2024 Aug 16:277:116773.
Eur J Pharmacol. 2023 Jan 5:938:175425.
Eur J Pharmacol. 2024 Jun 14:176746.
Eur J Pharmacol. 2025 Dec 5:1008:178303.
Eur J Pharmacol. 2025 Jul 15:999:177433.
Eur J Pharmacol. 2025 Jul 5:998:177534.
Eur J Pharmacol. 2025 Mar 25:177537.
Eur J Pharmacol. 2025 May 15:995:177427.
Eur J Pharmacol. 2026 Jan 10:1010:178362.
Exp Cell Res. 2020 Aug 1;393(1):112054.
Exp Cell Res. 2025 Mar 1;446(1):114471.
Exp Eye Res. 2018 Mar:168:2-11.
FASEB J. 2021 Feb;35(2):e20995.
FASEB J. 2022 Mar;36(3):e22147.
Free Radic Biol Med. 2021 Nov 20;176:228-240.
Free Radic Biol Med. 2024 Feb 20:212:309-321.
Free Radic Biol Med. 2024 Jun 19:S0891-5849(24)00531-8.
Free Radic Biol Med. 2025 Aug 13:240:183-196.
Front Med. 2021 Sep 23;8:746298.
Front Pharmacol. 2022 May 5;13:885053.
Front Pharmacol. 2022 Sep 26;13:997701.
Front Pharmacol. 2024 Aug 1:15:1413876.
Front Vet Sci. 2023 Nov 17:10:1277586.
Gene. 2019 Jun 5:700:139-148.
Heliyon. 2022 Aug 13;8(8):e10201.
Hematology. 2025 Dec;30(1):2545078.
Hum Cell. 2024 Oct 22;38(1):4.
Hum Exp Toxicol. 2025 Jan-Dec:44:9603271251324582.
Immunopharmacol Immunotoxicol. 2025 May 29:1-12.
Inflammation. 2024 Jun;47(3):853-873.
Int Immunopharmacol. 2020 Nov;88:107003.
Int Immunopharmacol. 2023 Sep:122:110558.
Int Immunopharmacol. 2024 Sep 6;142(Pt A):113055.
Int Immunopharmacol. 2025 May 23:159:114894.
Int Immunopharmacol. 2025 May 26:159:114954.
Int Immunopharmacol. 2025 Oct 15:167:115599.
Int J Biol Macromol. 2023 Dec 2;257(Pt 1):128588.
Int J Biol Macromol. 2025 Dec;334(Pt 2):149132.
Int J Cancer. 2025 Jul 4.
Int J Mol Med. 2023 Sep;52(3):78.
Int J Mol Sci. 2023 Jun 29;24(13):10838.
Int J Nanomedicine. 2024 Nov 21:19:12369-12387.
Int J Surg. 2025 Jul 2.
Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):21.
iScience. 2021 Sep 25;24(10):103170.
iScience. 2025 Apr 22;28(5):112513.
iScience. 2025 Apr 3;28(5):112344.
iScience. 2025 Jan 17;28(2):111831.
J Agric Food Chem. 2025 Jun 4;73(22):13891-13901.
J Allergy Clin Immunol. 2025 Sep 17:S0091-6749(25)00948-0.
J Biomed Inform. 2023 Jun:142:104383.
J Biomed Sci. 2025 May 30;32(1):54.
J Cachexia Sarcopenia Muscle. 2022 Aug;13(4):2017-2030.
J Cell Mol Med. 2021 Jan;25(2):1089-1099.
J Cell Mol Med. 2023 Dec;27(23):3911-3927.
J Cell Mol Med. 2024 Aug;28(16):e70044.
J Cereb Blood Flow Metab. 2022 Dec;42(12):2230-2244.
J Clin Immunol. 2025 Nov 15;45(1):160.
J Control Release. 2025 Nov 19:389:114427.
J Dent Sci. 2022 Jul;17(3):1281-1291.
J Ethnopharmacol. 2020 Sep 15;259:112882.
J Ethnopharmacol. 2023 Apr 6:305:116093.
J Ethnopharmacol. 2023 Jan 10:300:115725.
J Ethnopharmacol. 2024 Aug 17:118661.
J Ethnopharmacol. 2024 Aug 27:336:118740.
J Ethnopharmacol. 2024 Mar 1:321:117530.
J Ethnopharmacol. 2024 Nov 29:340:119128.
J Ethnopharmacol. 2024 Sep 13:118831.
J Ethnopharmacol. 2025 Jun 5:120082.
J Ethnopharmacol. 2026 Feb 28:357:120903.
J Extracell Vesicles. 2025 Sep;14(9):e70162.
J Funct Foods. 2023, 100: 105386.
J Funct Foods. 2024 Oct.
J Immunol Res. 2019 May 22:2019:8042097.
J Integr Med. 2024 Jan;22(1):83-92.
J Integr Neurosci. 2025 Aug 21;24(8):39532.
J Invest Surg. 2025 Dec;38(1):2535522.
J Mater Chem B. 2022 Oct 5;10(38):7847-7861.
J Med Chem. 2019 Jul 25;62(14):6561-6574.
J Med Chem. 2021 Mar 11;64(5):2725-2738.
J Med Chem. 2022 Dec 8;65(23):15710-15724.
J Med Chem. 2023 Jan 12;66(1):473-490.
J Med Chem. 2024 Sep 12;67(17):15738-15755.
J Mol Histol. 2024 Aug;55(4):503-512.
J Mol Histol. 2025 Aug 6;56(4):253.
J Nanobiotechnology. 2021 Dec 2;19(1):400.
J Nanobiotechnology. 2025 May 30;23(1):398.
J Nat Med. 2023 Mar;77(2):251-261.
J Oral Biosci. 2025 Mar;67(1):100571.
J Orthop Surg Res. 2025 Nov 14;20(1):997.
J Orthop Surg Res. 2025 Oct 29;20(1):943.
J Orthop Translat. 2024 Oct 4:49:82-95.
J Pharm Anal. 2025 Aug 9.
J Pharm Biomed Anal. 2016 May 30:124:216-227.
J Pharm Biomed Anal. 2021 Feb 20;195:113825.
J Transl Med. 2024 Dec 3;22(1):1095.
Life Sci. 2019 Mar 15:221:168-177.
Mater Today Bio. 2023 May 18:20:100667.
Mater Today Bio. 2025 Jun 21:33:102009.
Mayo Clinic. 2025.
Metabolism. 2025 Mar 30:156252.
Mol Biol Rep. 2024 Apr 21;51(1):562.
Mol Biol Rep. 2024 Mar 14;51(1):421.
Mol Immunol. 2021 Sep:137:163-173.
Mol Immunol. 2025 Apr:180:44-54.
Mol Med Rep. 2019 Dec; 20(6): 4933–4942.
Mol Nutr Food Res. 2024 Apr;68(7):e2300343.
Molecules. 2023 May 30;28(11):4441.
mSphere. 2024 Nov 21;9(11):e0067124.
Nanoscale Adv. 2025 Nov 21.
Nat Chem Biol. 2025 May 22.
Nat Commun. 2025 Aug 26;16(1):7954.
Nat Genet. 2024 Apr;56(4):663-674.
Nat Prod Bioprospect. 2023 Oct 7;13(1):36.
Nat Prod Commun. 2025 Mar 13.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8707-8723.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 31.
Neuron. 2025 Oct 10:S0896-6273(25)00706-8.
Neuroscience. 2025 Jun 21:577:144-153.
Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121.
Oncogene. 2021 Sep;40(35):5367-5378.
Oxid Med Cell Longev. 2022 Apr 14;2022:4913534.
Oxid Med Cell Longev. 2022 Mar 3;2022:3182368.
Patent. US20180263995A1.
Patent. US20210252159A1.
Patent. US20230404992A1.
Patent. US20240238358A1
Patent. US20240238358A1.
Patent. US20240261359A1.
Patent. US20250025542A1.
Patent. US20250129329A1.
Patent. US20250154468A1.
Pathol Res Pract. 2025 Oct 17;276:156273.
Pharmaceuticals (Basel). 2025 Feb 25;18(3):322.
Pharmaceuticals (Basel). 2025 Jan 29;18(2):181.
Phytomedicine. 2022 Apr:98:153959.
Phytomedicine. 2024 Dec:135:156043.
Phytomedicine. 2024 Dec:135:156168.
Phytomedicine. 2024 May 12:130:155733.
Phytomedicine. 2025 Apr:139:156508.
Phytomedicine. 2025 Feb 10:139:156491.
Phytomedicine. 2025 Feb:137:156362.
Phytomedicine. 2025 Jul:142:156698.
Phytomedicine. 2025 Jun 14:145:156957.
Phytomedicine. 2025 Jun 15:145:156984.
Phytomedicine. 2025 Mar 19:141:156663.
Phytomedicine. 2025 May 29:144:156929.
Phytomedicine. 2025 Oct 11:148:157400.
Phytomedicine. 2025 Oct 16:148:157413.
Phytomedicine. 2025 Oct:146:157091.
Phytomedicine. 2025 Sep 24:148:157306.
Phytomedicine. 2025 Sep 27:148:157336.
Phytother Res. 2024 Nov;38(11):5203-5224.
Phytother Res. 2025 Sep 18.
Plant Physiol. 2023 Feb 12;191(2):1416-1434.
Preprints. 2025 Sep 24.
Redox Biol. 2025 Aug 13:86:103820.
Redox Rep. 2025 Dec;30(1):2565861.
Res Sq. 2025 Jul 21.
Res Sq. 2025 May 08.
Res Sq. 2025 Oct 27.
Research Square Preprint. 2021 Jul.
Research Square Preprint. 2021 Oct.
Research Square Print. 2022 Aug.
Research Square Print. January 4th, 2023.
Sci Rep. 2024 Apr 30;14(1):9960.
Sci Rep. 2024 Sep 2;14(1):20370.
Sci Rep. 2025 Mar 15;15(1):8950.
Sci Rep. 2025 Oct 21;15(1):36691.
Sci Rep. 2025 Sep 25;15(1):32764.
Small Methods. 2024 Jul 22:e2400660.
Small. 2023 Aug;19(32):e2300409.
Small. 2025 Sep 5:e05946.
SSRN. 2022.
SSRN. 2023 Oct 10.
SSRN. 2023 Oct 30.
SSRN. 2023 Sep 11.
SSRN. 2024 Mar 8.
SSRN. 2024 May 30.
SSRN. 2025 Jul 7.
SSRN. 2025 Jun 3.
SSRN. 2025 Mar 31.
SSRN. 2025 Sep 11.
Stem Cell Res Ther. 2023 Dec 20;14(1):333.
Stem Cell Res Ther. 2024 Nov 28;15(1):456.
Stem Cell Res. 2021 Mar:51:102175.
Theranostics. 2025 Aug 16;15(17):9131-9158.
Toxicol Appl Pharmacol. 2024 Nov:492:117127.
Toxicol Appl Pharmacol. 2025 Aug 11:504:117510.
Toxicol Lett. 2019 Jul:309:42-50.
Transl Psychiatry. 2021 Mar 26;11(1):185.
Universidad de Navarra. 2024 Feb 28.
Utah State University. 2023 Feb 1.
World J Tradit Chin Med. 2025 Oct 28.
Antioxidants (Basel). 2025 Apr 1;14(4):428.
Biochem Pharmacol. 2025 Sep 17;242(Pt 3):117342.
Smiles O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(CO)=O)O)=C1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Hexadecadrol,Prednisolone F
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Reference compound
Manufacturer - Applications
COVID-19-anti-virus
Manufacturer - Category
Reference compound / Active compounds; API
Manufacturer - Targets
ADC Payload; Antibiotic; Autophagy; Bacterial; Complement System; Glucocorticoid Receptor; Mitophagy; SARS-CoV
Manufacturer - HS Code
H334, H360, H373, H410
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Molecular Weight
392.46
Product Description
Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist, apoptosis inducer, and common disease inducer in experimental animals, constructing models of muscle atrophy, hypertension, and depression. Dexamethasone can inhibit the production of inflammatory miRNA-155 exosomes in macrophages and significantly reduce the expression of inflammatory factors in neutrophils and monocytes. Dexamethasone also has potential for use in COVID-19 research[1][2][3][4].
Manufacturer - Research Area
Cancer; Infection; Endocrinology; Inflammation/Immunology; Cardiovascular Disease
Solubility
DMSO : 100 mg/mL (ultrasonic)|Ethanol : 8.33 mg/mL (ultrasonic)
Manufacturer - Pathway
Antibody-drug Conjugate/ADC Related; Anti-infection; Autophagy; Immunology/Inflammation; Vitamin D Related/Nuclear Receptor
Clinical information
Launched
UNSPSC Code
12352211
Precautionary
H334, H360, H373, H410

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 500 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?